Estrella Immunopharma, Inc.
ESLA
$1.72
$0.148.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.63M | 1.32M | 421.50K | -- | 1.80M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 396.90K | 163.90K | 522.80K | -- | 437.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.02M | 1.48M | 944.30K | 2.24M | 2.24M |
|
|
|||||
| Total Current Assets | 2.02M | 1.48M | 944.30K | 2.24M | 2.24M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.50M | 1.50M | 1.50M | -- | 1.50M |
| Total Assets | 3.52M | 2.98M | 2.44M | 3.74M | 3.74M |
|
|
|||||
| Total Accounts Payable | 5.60K | 8.20K | 14.00K | -- | 5.00K |
| Total Accrued Expenses | 12.96M | 8.88M | 4.25M | -- | 2.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.00K | 4.00K | 10.00K | -- | 4.00K |
| Total Finance Division Other Current Liabilities | 385.40K | 187.90K | 3.30K | -- | 43.60K |
| Total Other Current Liabilities | 385.40K | 187.90K | 3.30K | -- | 43.60K |
| Total Current Liabilities | 13.36M | 9.08M | 4.28M | 2.99M | 2.99M |
|
|
|||||
| Total Current Liabilities | 13.36M | 9.08M | 4.28M | 2.99M | 2.99M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.36M | 9.08M | 4.28M | 2.99M | 2.99M |
|
|
|||||
| Common Stock & APIC | 27.14M | 26.08M | 24.80M | -- | 24.13M |
| Retained Earnings | -36.38M | -31.58M | -26.03M | -22.88M | -22.88M |
| Treasury Stock & Other | -598.40K | -598.40K | -598.40K | -- | -504.90K |
| Total Common Equity | -9.84M | -6.09M | -1.83M | 746.30K | 746.30K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.84M | -6.09M | -1.83M | 746.30K | 746.30K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.84M | -6.09M | -1.83M | -- | 746.30K |
|
|
|||||